Akumentis Healthcare launches Clasepi, synthetic CBD for epilepsy
Clasepi comes with important usage considerations; it is not recommended for individuals allergic to cannabidiol or any of its…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lennox-Gastaut syndrome
Lupin launches Rufinamide Tablets USP in the US
Rufinamide is indicated for the treatment of the symptoms of Lennox-Gastaut Syndrome
Glenmark launches Rufinamide Tablets USP, 200 mg and 400 mg
It is indicated for the treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) along with other medicines
Lupin gets US FDA approval for Rufinamide Oral Suspension
It is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in paediatric patients one year…